These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 8729984)
1. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Berezowski K; Stastny JF; Kornstein MJ Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984 [TBL] [Abstract][Full Text] [Related]
2. Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen. DeCostanzo DC; Elias JM; Chumas JC Int J Gynecol Pathol; 1997 Jul; 16(3):245-9. PubMed ID: 9421090 [TBL] [Abstract][Full Text] [Related]
3. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Loy TS; Calaluce RD; Keeney GL Mod Pathol; 1996 Nov; 9(11):1040-4. PubMed ID: 8933513 [TBL] [Abstract][Full Text] [Related]
4. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity. Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771 [TBL] [Abstract][Full Text] [Related]
5. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958 [TBL] [Abstract][Full Text] [Related]
6. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. Goldstein NS; Bassi D; Uzieblo A Am J Clin Pathol; 2001 Aug; 116(2):246-52. PubMed ID: 11488072 [TBL] [Abstract][Full Text] [Related]
9. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [TBL] [Abstract][Full Text] [Related]
10. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors. Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145 [TBL] [Abstract][Full Text] [Related]
11. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma. Cameron RI; Ashe P; O'Rourke DM; Foster H; McCluggage WG Int J Gynecol Pathol; 2003 Jul; 22(3):272-6. PubMed ID: 12819395 [TBL] [Abstract][Full Text] [Related]
12. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Tot T Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990 [TBL] [Abstract][Full Text] [Related]
13. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Miettinen M Mod Pathol; 1995 May; 8(4):384-8. PubMed ID: 7567935 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary. Ueda G; Sawada M; Ogawa H; Tanizawa O; Tsujimoto M Gynecol Oncol; 1993 Nov; 51(2):219-23. PubMed ID: 7506222 [TBL] [Abstract][Full Text] [Related]
15. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Wauters CC; Smedts F; Gerrits LG; Bosman FT; Ramaekers FC Hum Pathol; 1995 Aug; 26(8):852-5. PubMed ID: 7543441 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521 [TBL] [Abstract][Full Text] [Related]
17. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study. Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498 [TBL] [Abstract][Full Text] [Related]
18. Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. McCluggage WG; Wilkinson N Histopathology; 2005 Sep; 47(3):231-47. PubMed ID: 16115224 [TBL] [Abstract][Full Text] [Related]
19. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273 [TBL] [Abstract][Full Text] [Related]
20. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors. Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]